ACCESS

From formulary access to patient support programs, we have your patients covered.

CONFIDENCE IN COVERAGE

of commercially insured patients have access to KEVZARA as of 09/2019

KEVZARA NATIONAL COVERAGE
KEVZARA is available nationally across multiple plans and segments.
PLAN NAME KEVZARA COVERAGE
STATUS
LIVES IMPACTED
Commercial
Aetna Covered for first-line use following cDMARD* 9.4 million
Anthem Covered for use after TWO of the following–
Enbrel®, Humira®, Remicade® or Simponl®*
13.5 million
Cigna Covered for use after TWO of the following–
Humira®, Enbrel®, Xeljanz® or Actemra®*
6.5 million
CVS Preferred access: covered for first-line use following cDMARD* 27 million
ESI Covered for use after TWO of the following–
Humira®, Enbrel®, Actemra®, Xeljanz® or Rinvoq™*
40 million
FEP Covered for use after ONE biologic DMARD* 5.4 million
Humana Preferred access: covered for first-line use following cDMARD* 1.2 million
TRICARE Covered for use after failure on Humira®* 7 million
VA Covered for use after failure on Enbrel®* 9.2 million
Medicare
ESI Covered for use after TWO of the following–
Humira®, Enbrel®, Actemra® or Xeljanz®*
1.5 million
Humana Preferred access: covered for first-line use following cDMARD* 8.1 million
MedImpact Preferred access: covered for first-line use following cDMARD* 386,000
Managed Medicaid
Anthem Covered for use after: Enbrel® and Humira®* 2.8 million
CVS Preferred access: covered for first-line use following cDMARD* 13 million
Fidells Cate Preferred access: covered for first-line use following cDMARD* 1.3 million
  • *Requires prior authorization.

Formulary data are provided by Managed Markets Insights Technology, LLC, and are current as of 09/2019.

A majority of patients, 70%, have access to KEVZARA after trying and failing with up to 2 products (double-step edit). KevzaraConnect® is designed to support and simplify the KEVZARA journey for your patients by providing coverage support, including assistance with navigating the complex insurance process.